Clinical Trial

Prehabilitation and RecOVERy From Surgery for Breast Cancer Study

Study acronym: PROVERB
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
Background and study aims: Nine out of ten women experience some negative effects due to their disease or its treatment such as anxiety, depression, weight gain and low quality of life. Research shows that exercise may help women overcome some of these effects. The investigators also know that most women become physically inactive after cancer treatment. Therefore, The investigators feel it is important that women get into a routine of doing regular exercise before they start their cancer treatment, this is called prehabilitation. The investigators believe that prehabilitation might help to build confidence and help women to continue exercising after their cancer treatment. The investigators are doing this study to find out if a remote (NHS Attend Anywhere), multimodal (aerobic, resistance and targeted exercise), behavioural change (Health Action Process Approach (HAPA), dyadic coping (the collective effort to dealing with the stress of breast cancer diagnosis and treatment), and wearable technology), multiphasic (pre- and post-surgery) intervention is feasible in the short time frame between diagnosis of breast cancer and surgery (less than 31 days). The investigators would also like to find out whether it is feasible for women to begin an exercise rehabilitation programme two weeks after their operation. If successful, the results will potentially enable us in the future to tailor the support gievn to women to help them prepare and recover from breast cancer treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-12; most recent amendment 2024-08-07.
Status change: Recruiting → Active, Not Recruiting 2024-08-07
Status change: Not Yet Recruiting → Recruiting 2023-07-25
Trial Details
NCT Number NCT05901142
Lead Sponsor University Hospitals of Derby and Burton NHS Foundation Trust
Collaborators: University of Wolverhampton, University of Hull, Sheffield Teaching Hospitals NHS Foundation Trust, University of Bath, Aston University, Staffordshire University
Conditions Exercise, Breast Neoplasm Female
Enrollment 34 participants
Start Date 2023-06-16
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-09